Comparison of Vaginal Isosorbide Mononitrate with Prostaglandin E2 for Pre-Induction Cervical Ripening at Term by Mukhtar, Ayesha
Journal of Rawalpindi Medical College (JRMC); 2013;17(1):110-112 
 
 110 
Original Article  
Comparison of Vaginal Isosorbide Mononitrate with 
Prostaglandin E2 for Pre-Induction Cervical Ripening 
at Term 
 
Ayesha Mukhtar, Farzana Kazmi, Farah Rehana 
Department of Gynae/Obs, District Head Quarters Hospital and Rawalpindi Medical College. 
 
Abstract 
Background : To compare the efficacy of nitric 
oxide donor isosorbide mononitrate (IMN) with 
prostaglandin E2 (PGE2) on the cervical ripening and 
induction of labour at term.  
Methods:  In this  descriptive study sixty patients were 
divided into two equal groups.Group A consisted of  30 
patients to whom Prostaglandin E2 was given. Group B 
included 30 patients to whom isosorbide mononitrate was 
given. Three  mg of prostaglandin E2 was placed in 
posterior vaginal fornix in group A patients and dose was 
repeated every six hours up to 2 doses.  40 mg of isosorbide 
mononitrate (Monis) was given vaginally in group B 
patients and dose was repeated every four hour up to 2 
doses. During this procedure intermittent fetal heart rate 
and uterine contraction was noted. Time of first and 
second dose of tablet was noted and time at which patient 
delivers was also noted to know the induction-delivery 
interval. If Bishop Score improved more than 5 then 
amniotomy followed by augmentation, if necessary was 
performed. If Bishop score did not improve after 2 doses, it 
was considered induction failure and an indication for 
caesarean section. Possible side effects were also noted.  
Results: Induction to delivery interval was longer  in 
IMN group as compared to PGE2. There was no case of 
hyperstimulation in both groups. Side effects of  IMN 
were  mild and not clinically significant .  
Conclusion:  Like prostaglandin E2, the nitric oxide 
donor Isosorbide Mononitrate can be used for cervical 
ripening and induction of labour.  
Key Words:  Labour, Induction, Nitric Oxide Donors, 
PGE2, Cervical Ripening. 
 
Introduction 
     Degree of cervical ripening is of fundamental 
importance for successful induction of labour as it 
culminates in softening and distensibility of cervix.  
Normally labour starts spontaneously but in 10% to 
20% cases it has to be induced. The mechanism of 
cervical ripening and labour  is still not fully 
understood but is thought to involve different 
hormones including oestrogens, progesterone, 
prostaglandins and nitric oxide (NO).  Induction of 
labour is the stimulation of regular uterine 
contractions before the spontaneous onset of labour & 
cervical ripening is the process that culminates in the 
softening and distensibility of cervix, thus facilitating 
labour and delivery.1  Induction of labour is indicated 
when delivery is more beneficial for mother or fetus 
than continuation of pregnancy. 2  Various mechanical 
and pharmacological methods are used for induction 
of labour 3. Indications for labour induction are 
postdates, pre labour rupture of membranes, medical 
disorders (PIH, diabetes, preeclampsia).4 As 15% of all 
gravid women required aid in cervical ripening and 
labour induction there is widespread interest in 
demand for an effective and safe method.5 Recently 
nitric oxide donor isosorbide mononitrate (IMN) has 
been evaluated for cervical ripening and induction of 
labour at term. 6  It produces cervical ripening without 
hyper stimulation of uterus  and fetal heart rate 
abnormalities. 2, 7  Patient induced with isosorbide 
mononitrate have short in patient stay before delivery 
and short duration of labour without any serious side 
effects. It is cheap and widely available. 8- 10 
Exogenous prostaglandins, particularly 
dinorostone (PGE2) are frequently used as cervical 
ripening agents but their use is associated with side 
effects, for example nausea, vomiting, diarrhoea, 
abdominal cramps, chills, shivering and uterine hyper 
stimulation more than isosorbide mononitrate. 11,12 
 
Patients and Methods  
   This descriptive study was conducted at  
Department of Gynae/Obs DHQ Teaching Hospital, 
Rawalpindi  from   June 2007 to November, 2007. Sixty 
women were divided into Group A: Prostaglandin E2 
and Group B: Isosorbide Mononitrate. Sampling was 
convenience non-probability. Inclusion criteria were 
singleton gestation, Cephalic presentation, 37 weeks or 
more of pregnancy, reactive fetal heart rate pattern 
and obstetrical indication for labour induction. 
Exclusion criteria were Cervical dilatation more than 3 
cm or Bishop more than 5cm, any contra indication for 
1
1 
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induction such as placenta praevia, previous C-
Section, evidence of cephalopelvic disproportion, 
evidence of chorioamnionitis,  any contra indication to 
use of prostaglandin and isosorbide mononitrate. 
     Proper informed consent was taken from each 
woman. Initial evaluation was done by taking 
complete history, general physical examination, 
systemic and obstetric examination. Fetal assessment 
was done by Cardiotocography and Biophysical 
profile. A specially designed proforma was used for 
data collection. Three mg of prostaglandin E2 was 
placed in posterior vaginal fornix in group A patient 
and dose was repeated every six hours up to 2 doses, 
similarly 40 mg of isosorbide mononitrate (MONIS) 
was given  in group B patients and dose was repeated 
every four hours up to 2 doses. During this procedure 
intermittent fetal heart rate and uterine contraction 
was noted. Time of first and second dose of tablet was 
noted and time at which patient delivers was also 
noted to know the induction-delivery interval. No 
further dose was given if patient went into labour or 
signs of fetal distress like tachycardia and bradycardia 
or moderate to severe decelerations in CTG are 
recorded or uterine hyper stimulations noted. If 
Bishop Score did not improve after 2 doses, it was 
considered failed induction. 
 
Results 
     Both groups had minimum Bishop Score of 2 and 
maximum of 5 having no significant statistical value 
(Table 1). Primary outcome measure was induction 
delivery interval (Table 2). Mean induction delivery 
interval was 9.5 hours in PGE2 group and 13 hours in 
IMN group. Group A patients delivered approx about 
4 hours earlier than patients in group B. There was no 
statistically valuable difference in mode of delivery 
between 2 groups as shown in (Table 3).   
Table 1: Bishop Score 
Group Bishop Score p-Value 
 2 3 4 5 
0.704 A  PGE2 4 5 10 11 
B  IMN 2 8 10 10 
 
Table 2: Induction to delivery interval (Hours) 
Group Range (Mean + SD) p-Value  
A  PGE2 5-16.5 (9.5 + 2.46) 
.000 
B  IMN 7-18 ( 18+ 3.93) 
    Thirty seven percent  patients required 2 tablets in 
group A as compared to 73% in group B(Table 
4).There were significant side effect ( headache and 
palpitation) in group B. There were no cases of uterine 
hyper stimulation in both groups.  Nausea vomiting 
was 23.3%  in group A and 13% in group B and only 2 
cases of shivering were recorded in group A and none 
in group B. (Table 5) 
 
Table 3: Mode of delivery 
 Mode of delivery    
 
A  PGE2 B  IMN 
Spontaneous vaginal Delivery  24 (80%) 22 (73%) 
LSCS due to failed progress 3 (10%) 4 (13%) 
LSCS due to fetal distress 2 (6.7%) 0 (3%) 
LSCS due to failed induction 1 (3.3%) 4 (13%) 
                  
Table 4: Number of tablets used 
Number of Tablets  A  PGE2 B  IMN 
1 19 (63.3%) 8 (26.7%) 
2 11 (36.7%) 22 (73.3%) 
Table 5: Side effects 
 A  PGE2 B  IMN p-
VALUE 
Headache 1 (3.3%) 8 (26.6%) .011 
Palpitation 0 4 (13%) .038 
Nausea and 
Vomiting  
7 (23.3%) 4 (13.3%) 
.317 
Shivering  2 (6.6%) 0 .15 
Hyper 
stimulation  
0 (0) 0 (0) 
0 
            
Discussion 
      In a randomized comparison (PRIM study) it was 
found that mean duration of induction delivery was 
greater in IMN than PGE2 and no side effects were 
found in IMN group.3 However, 7 % of patients in 
PGE2 group had abnormal fetal heart rate pattern. 
Although IMN was less effective, maternal satisfaction 
was greater. In present  study, induction interval in 
IMN group was also greater ( 13 hours in IMN and 9.5 
hours for PGE2 ). There was no significant difference 
in caesarean section rate between two groups. (20 % 
for PGE2 versus 26.6% for IMN ). There was no case of 
hyperstimulation in both groups.  Mild headache was 
3.3% in PGE2 group and 26.6% in IMN group. There 
was no case of palpitations in group A as compared to 
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13% in group B. A  slight increase in frequency of side 
effects in present  study can be due to the use of two  
tablets of 40 mg of IMN in most patients with interval 
of 4 hours, while in PRIM study only single dose was 
used. 13 
     PRIM study concluded that PGE2 was more 
effective than IMN in inducing change in modified 
Bishop Score and same is the case in present  study 
(73% of patients required 2 tablets of 40mg of IMN as 
compared to 36% in PGE2 group). 63% of patients in 
PGE2 group as compared to 26% in IMN group. Our 
study also pointed out that IMN was not very much 
effective in inducing change in poor Bishop Score as 
caesarean section due to failed induction was 13% in 
IMN group as compared to 3% in PGE2 group. 
     Another study published in 2000 by Yuthika 
Sherma and Sunesh Kumar concluded that Nitric 
Oxide donors glyceryl trinitrate was also associated 
with lower episodes of tachysystoles (0% versus 9%) 
but medium Bishop Score after 12 hours was lower 
and headache and palpitations were more frequent 
with glyceryl trinitrate as compared t o PGE2 group.14 
Another randomized controlled study was carried out 
comparing use of IMN simultaneously with 
dinoprostone to dinoprostone alone and concluded 
that vaginally administred IMN does not play a role in 
promoting delivery in term pregenancy if given at the 
same time with dinoprostone. 15  
     A randomized controlled trial was carried out to 
compare out patients vaginal administration of nitric 
oxide donor IMN for cervical ripening in labour 
induction using 40mg of IMN for post term 
pregnancies  and concluded that it seems to be 
effective, safe and well tolerated procedure. 16  Present 
study concluded that induction of labour with IMN is 
a safe and well tolerated. Majority (86%) went into 
labour within 24 hours and there was no case of 
hyperstimulation and side effects were also mild.  
 As there are concerns on the use of 
prostaglandins for induction of labor on out door basis 
due to hyperstimulation leading to fetal hypoxia it is 
not recommended for use on outdoor basis. It is also 
not associated with fetal heart rate abnormalities.17  
 
Conclusion 
1.IMN is effective and cheaper alternative to PGE 2 for 
cervical ripening and induction of labour at term.  
2.Induction delivery interval is prolonged but it is 
convenient to use and well tolerated.  
3.It does not cause uterine hyper stimulation. Side 
effects like nausea, vomiting and palpitations are mild 
and not clinically significant.  
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